Oragenics, Inc. – AMEX:OGEN
Oragenics stock price today
$1.03
+0.57
+127.12%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 23 hours
Oragenics stock price monthly change
-59.46%
month
Oragenics stock price quarterly change
-59.46%
quarter
Oragenics stock price yearly change
-91.75%
year
Oragenics key metrics
Market Cap | 4.39M |
Enterprise value | 23.59B |
P/E | -0.42 |
EV/Sales | 271220.76 |
EV/EBITDA | -1454.01 |
Price/Sales | 271371.58 |
Price/Book | 1769.78 |
PEG ratio | N/A |
EPS | -7.19 |
Revenue | N/A |
EBITDA | -10.01M |
Income | -20.26M |
Revenue Q/Q | -100% |
Revenue Y/Y | -106.42% |
Profit margin | -18713.49% |
Oper. margin | -18803.75% |
Gross margin | 0% |
EBIT margin | -18803.75% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOragenics stock price history
Oragenics stock forecast
Oragenics financial statements
| Jun 2023 | 13.16K | -3.05M | -23175.46% |
|---|---|---|---|
| Sep 2023 | 7.46K | -2.01M | -26960.69% |
| Dec 2023 | -37.65K | -12.74M | 33855.02% |
| Mar 2024 | 0 | -2.45M |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 1.87% |
|---|---|
| 2020 | 2.61% |
| 2021 | 2.22% |
| 2022 | |
| 2023 |
| Jun 2023 | 8464486 | 1.20M | 14.26% |
|---|---|---|---|
| Sep 2023 | 7899428 | 1.40M | 17.75% |
| Dec 2023 | 4966335 | 1.79M | 36.21% |
| Mar 2024 | 3533951 | 908.68K | 25.71% |
| Jun 2023 | -2.57M | 0 | -107.89K |
|---|---|---|---|
| Sep 2023 | -1.50M | 63.71K | 732.11K |
| Dec 2023 | -1.10M | -999.99K | -180.59K |
| Mar 2024 | -3.06M | 0 | 1.65M |
Oragenics alternative data
| Aug 2023 | 6 |
|---|---|
| Sep 2023 | 6 |
| Oct 2023 | 6 |
| Nov 2023 | 6 |
| Dec 2023 | 6 |
| Jan 2024 | 6 |
| Feb 2024 | 6 |
| Mar 2024 | 6 |
| Apr 2024 | 6 |
| May 2024 | 6 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Oragenics other data
2.45%
-6.63%
of OGEN is owned by hedge funds
10
-16
46.17K
-124.82K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2024 | 0 | 3663 |
| Insider | Compensation |
|---|---|
Mr. Michael O. Sullivan CPA (1956) Chief Financial Officer, Sec., Treasurer & Interim Principal Executive Officer | $297,210 |
Dr. Martin Handfield M.Sc., Ph.D. (1971) Senior Vice President of Discovery Research | $250,050 |
Dr. Frederick W. Telling Ph.D. (1952) Executive Chairman | $107,500 |
-
What's the price of Oragenics stock today?
One share of Oragenics stock can currently be purchased for approximately $1.03.
-
When is Oragenics's next earnings date?
Unfortunately, Oragenics's (OGEN) next earnings date is currently unknown.
-
Does Oragenics pay dividends?
No, Oragenics does not pay dividends.
-
How much money does Oragenics make?
Oragenics has a market capitalization of 4.39M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 71.37% to 37.65K US dollars.
-
What is Oragenics's stock symbol?
Oragenics, Inc. is traded on the AMEX under the ticker symbol "OGEN".
-
What is Oragenics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Oragenics?
Shares of Oragenics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Oragenics's key executives?
Oragenics's management team includes the following people:
- Mr. Michael O. Sullivan CPA Chief Financial Officer, Sec., Treasurer & Interim Principal Executive Officer(age: 69, pay: $297,210)
- Dr. Martin Handfield M.Sc., Ph.D. Senior Vice President of Discovery Research(age: 54, pay: $250,050)
- Dr. Frederick W. Telling Ph.D. Executive Chairman(age: 73, pay: $107,500)
-
How many employees does Oragenics have?
As Jul 2024, Oragenics employs 5 workers, which is 17% less then previous quarter.
-
When Oragenics went public?
Oragenics, Inc. is publicly traded company for more then 21 years since IPO on 25 Feb 2004.
-
What is Oragenics's official website?
The official website for Oragenics is oragenics.com.
-
Where are Oragenics's headquarters?
Oragenics is headquartered at 4902 Eisenhower Boulevard, Tampa, FL.
-
How can i contact Oragenics?
Oragenics's mailing address is 4902 Eisenhower Boulevard, Tampa, FL and company can be reached via phone at +81 32867900.
Oragenics company profile:
Oragenics, Inc.
oragenics.comExchange:
AMEX
Full time employees:
5
Industry:
Biotechnology
Sector:
Healthcare
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.
4902 Eisenhower Boulevard
Tampa, FL 33634
Tampa, FL 33634
CIK: 0001174940
ISIN: US6840235005
CUSIP: 684023500
